PK

Philip Krause

Mesoblast Limited | Non-Executive Director
With over 30 years of experience at the Food and Drug Administration, Dr. Krause has a unique combination of scientific, regulatory, clinical, and public health experience. He is a physician with board certification in internal medicine and infectious diseases and a researcher with over 100 publications on topics spanning clinical evaluation of vaccines, viral pathogenesis and immunology, and biological product development. He is currently an independent consultant, providing strategic and regulatory advice related to biological product development. He recently served as deputy director of FDA's Office of Vaccines Research and Review, where he led assessments of biological products for evaluation and licensure and helped to oversee the development and evaluation of all vaccines authorized and licensed in the US from 2011 to 2021.

Company and Role

Company
Title
Tenure
Since
MSB
Mesoblast Limited
  • Non-Executive Director
2yrs, 3mthMar 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
MSB
Mesoblast Limited
28/12/23100,00057,500200,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
MSB
Mesoblast Limited
28/12/23
Buy
37,500$1.108$41,536On-market trade
MSB
Mesoblast Limited
05/06/23
Buy
20,000$3.705$74,100On-market trade
MSB
Mesoblast Limited
16/01/23
Issued
200,000$0.975$195,000Issue of options